Reuters - Amgen Inc. on Thursday
posted quarterly profit that topped Wall Street expectations,
even as sales of its biggest drug, Aranesp, fell 19 percent in
the United States amid safety concerns.
Source: http://rss.news.yahoo.com
Thursday, July 26, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment